ArticleActa oncologica (Stockholm, Sweden)2026

Stakeholders' experiences with a clinician-led access programme linking evidence generation and reimbursement for precision cancer treatments: the drug access protocol in the Netherlands.

Christine Leopold et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.